CVS Health Corporation (NYSE:CVS) Short Interest Update

CVS Health Corporation (NYSE:CVS) saw a significant decline in short interest during the month of February. As of February 13th, there was short interest totaling 16,528,176 shares, a decline of 18.8% from the January 29th total of 20,354,623 shares. Based on an average daily trading volume, of 9,397,283 shares, the days-to-cover ratio is currently 1.8 days. Currently, 1.3% of the shares of the company are short sold. Currently, 1.3% of the shares of the company are short sold. Based on an average daily trading volume, of 9,397,283 shares, the days-to-cover ratio is currently 1.8 days.

CVS Health Price Performance

CVS stock traded up $0.08 on Wednesday, reaching $80.57. 6,803,124 shares of the company’s stock were exchanged, compared to its average volume of 8,302,811. CVS Health has a twelve month low of $58.35 and a twelve month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The stock has a fifty day moving average of $78.50 and a 200-day moving average of $77.47. The firm has a market cap of $102.50 billion, a PE ratio of 58.38, a P/E/G ratio of 0.84 and a beta of 0.49.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter last year, the firm posted $1.19 EPS. The business’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, equities analysts predict that CVS Health will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were given a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

Institutional Investors Weigh In On CVS Health

A number of large investors have recently added to or reduced their stakes in CVS. Harbor Capital Advisors Inc. increased its stake in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd increased its position in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares in the last quarter. Swiss RE Ltd. acquired a new position in CVS Health in the 4th quarter valued at about $26,000. Sankala Group LLC purchased a new position in CVS Health in the 4th quarter valued at about $28,000. Finally, Mcguire Capital Advisors Inc. purchased a new stake in shares of CVS Health during the fourth quarter worth about $28,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently commented on CVS. Weiss Ratings reiterated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Truist Financial set a $100.00 target price on shares of CVS Health in a research note on Wednesday, December 10th. Bank of America dropped their price target on CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. UBS Group reaffirmed an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Barclays boosted their target price on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.77.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.